Cargando…
Use of REGEN-COV in children after heart transplantation for treatment and post-exposure prophylaxis of COVID-19
COVID-19 pandemic continues to evolve and new variants like Delta and Omicron have been discovered. REGEN-COV is a recombinant human monoclonal antibody to the spike protein of SARS-CoV-2 which received emergency use authorisation for treatment and post-exposure prophylaxis in patients with high ris...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cambridge University Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304944/ https://www.ncbi.nlm.nih.gov/pubmed/35798332 http://dx.doi.org/10.1017/S1047951122002190 |